Evidence map›Paper›PMID 37551388›Full record

ArticleAsian biomedicine : research, reviews and news2020

Production and differential activity of recombinant human wild-type G6PD and G6PD

Lelamekala Vengidasan, Muhammad Amir Yunus, Narazah Mohd Yusoff, Badrul Hisham Yahaya, Ida Shazrina Ismail

Abstract read
In one paragraph

Article in Asian biomedicine : research, reviews and news, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lelamekala VengidasanRegenerative Medicine Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Malaysia, Bertam13200, Penang, Malaysia.ORCID https://orcid.org/0000-0002-8832-8144
Muhammad Amir YunusInfectomics Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam13200, Penang, Malaysia.ORCID https://orcid.org/0000-0002-7411-0769
Narazah Mohd YusoffRegenerative Medicine Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Malaysia, Bertam13200, Penang, Malaysia.ORCID https://orcid.org/0000-0001-6801-2508
Badrul Hisham YahayaRegenerative Medicine Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Malaysia, Bertam13200, Penang, Malaysia.ORCID https://orcid.org/0000-0002-3295-9676
Ida Shazrina IsmailRegenerative Medicine Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Malaysia, Bertam13200, Penang, Malaysia.ORCID https://orcid.org/0000-0003-1876-2073

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glucose-6-phosphate dehydrogenase (G6PD) is essential to produce reduced nicotinamide adenine dinucleotide phosphate, which is required to protect cells against oxidative stress. G6PD deficiency is a genetic variation that may lead to hemolysis with potential consequences, such as kidney failure, and patients often experience low quality of life. Objectives: To establish a simple, efficient, and optimized method to produce a G6PD Methods: Results: Both amplicons were successfully cloned into a pET26b(+) expression vector and transformed into Conclusions: We successfully cloned, expressed, and purified both wild-type G6PD and G6PD

Indexed as

cloningglucose-6-phosphate dehydrogenase Viangchan, humanglucosephosphate dehydrogenase deficiencyphenotypeprotein expression

Identifiers

PMID37551388
PMCPMC10373393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.